Emami Q3 Results: Emami Limited has given investors another chance to be happy with the December 2024 quarter results. The company earned a net profit of ₹ 278.99 crore in this quarter, which is 8% higher than ₹ 258.4 crore in the same quarter of last year. This FMCG company from Kolkata has also increased its income by 5.3%, which increased from ₹ 996.3 crore to ₹ 1,049.5 crore. The company that produced boroplus showed that not only the skin, but also the brightness of their profits in the cold.
The company’s EBITDA i.e. interest, tax, depression and earning earnings before the earnings increased by 6% to ₹ 386.5 crore. However, the margin remained almost stable during this period and remained at 36.8%, which was 36.5% in the same period last year.
Emami has also given a gift for shareholders. The board announced the second interim dividend for the financial year 2024-25, which is ₹ 4 per share. This dividend will be given on 43.65 crore shares. The record date for this dividend has been fixed on 4 February 2025. Earlier, in November 2024, the company also declared the first interim dividend ₹ 4 per share.
Emami also took some major decisions in this quarter. The company has Helios Lifestyle Pvt. I invest ₹ 177.6 crore and purchased the remaining shares, which made her the entire owner of the company. Also, Cannis Lupus Services India Pvt. Increased its stake from 30% to 47%. The company converted 10,165 compulsory convertible preference shares into equity for this.
However, the stock market showed a little pressure on Emami’s shares. The company’s shares fell 2.95% to close at ₹ 535.05 on the NSE. This decline was higher than a decline of 1.14% in Nifty 50 that day. But in the last 12 months, the company’s shares have gone up 7.1%.